Baidu
map

张伯礼院士荣获2016年吴阶平医学奖

2016-11-24 马晓蓓 健康界

张伯礼院士荣获2016年吴阶平医学奖,王喜军、刘祖国、黄晓军和蔡秀军教授分获2016年吴阶平医药创新奖。11月24日,吴阶平医学基金会对外公布,将2016年吴阶平医学奖授予张伯礼院士,以表彰他对中国中药现代化研究和中医药发展所做出的杰出贡献。同时公布的还有2016年吴阶平医药创新奖,分别授予王喜军教授、刘祖国教授、黄晓军教授、蔡秀军教授,以表彰四位获奖人在他们各自学科领域中所做出的创新性成就和突出

张伯礼院士荣获2016年吴阶平医学奖,王喜军、刘祖国、黄晓军和蔡秀军教授分获2016年吴阶平医药创新奖。

11月24日,吴阶平医学基金会对外公布,将2016年吴阶平医学奖授予张伯礼院士,以表彰他对中国中药现代化研究和中医药发展所做出的杰出贡献。
同时公布的还有2016年吴阶平医药创新奖,分别授予王喜军教授、刘祖国教授、黄晓军教授、蔡秀军教授,以表彰四位获奖人在他们各自学科领域中所做出的创新性成就和突出贡献。

据吴阶平医学基金会理事长晓萌介绍,2016年吴阶平医学奖和医药创新奖颁奖典礼将于12月20日在广东省中山市举行。

获奖人简介:

张伯礼(1948年2月)中医内科学专家、教授,中国工程院院士、中国中医科学院院长、天津中医药大学校长。

张伯礼教授从事心脑血管疾病防治和中医药现代化研究30余年。带领团队连续承担了3个国家“973”项目——方剂配伍关键科学问题的基础研究,通过多学科协同攻关,开拓了以“组分配伍”研制现代中药的模式和相关技术体系,建立了有效组分制备、分析及活性评价等共用技术,建立了基线等比增减、极性分段筛选、药对协同效应等组分配伍优选设计方法,建立了“标准组分、组效关系、组分配伍、优化设计”的组分中药研发模式和技术路线。

王喜军(1961年12月),中药学专家、教授,现任黑龙江中医药大学副校长。

王喜军教授长期从事中医药理论基础研究及重要创新药物研究,尤其在中药有效性评价及药效物质基础研究方面取得了突出成绩。

刘祖国(1962年11月),眼科学专家、教授,现任厦门大学医学院院长、厦门大学眼科研究所所长。

刘祖国教授在眼表与角膜疾病领域进行了长期而系统的临床及基础研究工作,创建了我国首个眼表疾病研究中心及干眼专科门诊,是我国眼表疾病学科及干眼学科的建立者。

黄晓军(1964年8月),血液病专家、教授,现任北京大学血液病研究所所长。

黄晓军教授在造血干细胞移植、复发防治及血液病治疗等领域取得一系列原创成果,对促进我国血液学进步和提高我国在该领域的国际学术地位做出了开创性贡献。

蔡秀军(1963年11月),外科学专家、教授,现任浙江大学医学院附属邵逸夫医院院长。

蔡秀军教授长期工作在腹部外科临床一线,通过器械研发、技术创新、术式创建攻克了临床实践中的多个难题,拓展了腹腔镜技术的应用范围。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=158309, encodeId=2e6815830948, content=支持支持, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1cdf1948157, createdName=Peter程, createdTime=Sat Nov 26 16:23:08 CST 2016, time=2016-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1394253, encodeId=8e431394253c5, content=<a href='/topic/show?id=796549911d9' target=_blank style='color:#2F92EE;'>#张伯礼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49911, encryptionId=796549911d9, topicName=张伯礼)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/E33DC517C2EC449E463E3D01D81745BA/100, createdBy=75e12500157, createdName=ms1756883563247400, createdTime=Sat Nov 26 08:08:00 CST 2016, time=2016-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457286, encodeId=fc9f145e2865c, content=<a href='/topic/show?id=089e393e1c4' target=_blank style='color:#2F92EE;'>#吴阶平#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39371, encryptionId=089e393e1c4, topicName=吴阶平)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64955868177, createdName=zhmscau, createdTime=Sat Nov 26 08:08:00 CST 2016, time=2016-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543477, encodeId=580c15434e7ba, content=<a href='/topic/show?id=274e340e5fd' target=_blank style='color:#2F92EE;'>#医学奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34075, encryptionId=274e340e5fd, topicName=医学奖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=250d13588803, createdName=斯嘉莉, createdTime=Sat Nov 26 08:08:00 CST 2016, time=2016-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1575397, encodeId=da1715e53974f, content=<a href='/topic/show?id=fab8393e4f9' target=_blank style='color:#2F92EE;'>#吴阶平医学奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39374, encryptionId=fab8393e4f9, topicName=吴阶平医学奖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd2816125954, createdName=s_pl2013, createdTime=Sat Nov 26 08:08:00 CST 2016, time=2016-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=157934, encodeId=8f5915e93408, content=牛人牛人!, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Thu Nov 24 20:21:03 CST 2016, time=2016-11-24, status=1, ipAttribution=)]
    2016-11-26 Peter程

    支持支持

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=158309, encodeId=2e6815830948, content=支持支持, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1cdf1948157, createdName=Peter程, createdTime=Sat Nov 26 16:23:08 CST 2016, time=2016-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1394253, encodeId=8e431394253c5, content=<a href='/topic/show?id=796549911d9' target=_blank style='color:#2F92EE;'>#张伯礼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49911, encryptionId=796549911d9, topicName=张伯礼)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/E33DC517C2EC449E463E3D01D81745BA/100, createdBy=75e12500157, createdName=ms1756883563247400, createdTime=Sat Nov 26 08:08:00 CST 2016, time=2016-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457286, encodeId=fc9f145e2865c, content=<a href='/topic/show?id=089e393e1c4' target=_blank style='color:#2F92EE;'>#吴阶平#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39371, encryptionId=089e393e1c4, topicName=吴阶平)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64955868177, createdName=zhmscau, createdTime=Sat Nov 26 08:08:00 CST 2016, time=2016-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543477, encodeId=580c15434e7ba, content=<a href='/topic/show?id=274e340e5fd' target=_blank style='color:#2F92EE;'>#医学奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34075, encryptionId=274e340e5fd, topicName=医学奖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=250d13588803, createdName=斯嘉莉, createdTime=Sat Nov 26 08:08:00 CST 2016, time=2016-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1575397, encodeId=da1715e53974f, content=<a href='/topic/show?id=fab8393e4f9' target=_blank style='color:#2F92EE;'>#吴阶平医学奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39374, encryptionId=fab8393e4f9, topicName=吴阶平医学奖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd2816125954, createdName=s_pl2013, createdTime=Sat Nov 26 08:08:00 CST 2016, time=2016-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=157934, encodeId=8f5915e93408, content=牛人牛人!, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Thu Nov 24 20:21:03 CST 2016, time=2016-11-24, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=158309, encodeId=2e6815830948, content=支持支持, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1cdf1948157, createdName=Peter程, createdTime=Sat Nov 26 16:23:08 CST 2016, time=2016-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1394253, encodeId=8e431394253c5, content=<a href='/topic/show?id=796549911d9' target=_blank style='color:#2F92EE;'>#张伯礼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49911, encryptionId=796549911d9, topicName=张伯礼)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/E33DC517C2EC449E463E3D01D81745BA/100, createdBy=75e12500157, createdName=ms1756883563247400, createdTime=Sat Nov 26 08:08:00 CST 2016, time=2016-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457286, encodeId=fc9f145e2865c, content=<a href='/topic/show?id=089e393e1c4' target=_blank style='color:#2F92EE;'>#吴阶平#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39371, encryptionId=089e393e1c4, topicName=吴阶平)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64955868177, createdName=zhmscau, createdTime=Sat Nov 26 08:08:00 CST 2016, time=2016-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543477, encodeId=580c15434e7ba, content=<a href='/topic/show?id=274e340e5fd' target=_blank style='color:#2F92EE;'>#医学奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34075, encryptionId=274e340e5fd, topicName=医学奖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=250d13588803, createdName=斯嘉莉, createdTime=Sat Nov 26 08:08:00 CST 2016, time=2016-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1575397, encodeId=da1715e53974f, content=<a href='/topic/show?id=fab8393e4f9' target=_blank style='color:#2F92EE;'>#吴阶平医学奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39374, encryptionId=fab8393e4f9, topicName=吴阶平医学奖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd2816125954, createdName=s_pl2013, createdTime=Sat Nov 26 08:08:00 CST 2016, time=2016-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=157934, encodeId=8f5915e93408, content=牛人牛人!, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Thu Nov 24 20:21:03 CST 2016, time=2016-11-24, status=1, ipAttribution=)]
    2016-11-26 zhmscau
  4. [GetPortalCommentsPageByObjectIdResponse(id=158309, encodeId=2e6815830948, content=支持支持, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1cdf1948157, createdName=Peter程, createdTime=Sat Nov 26 16:23:08 CST 2016, time=2016-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1394253, encodeId=8e431394253c5, content=<a href='/topic/show?id=796549911d9' target=_blank style='color:#2F92EE;'>#张伯礼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49911, encryptionId=796549911d9, topicName=张伯礼)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/E33DC517C2EC449E463E3D01D81745BA/100, createdBy=75e12500157, createdName=ms1756883563247400, createdTime=Sat Nov 26 08:08:00 CST 2016, time=2016-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457286, encodeId=fc9f145e2865c, content=<a href='/topic/show?id=089e393e1c4' target=_blank style='color:#2F92EE;'>#吴阶平#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39371, encryptionId=089e393e1c4, topicName=吴阶平)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64955868177, createdName=zhmscau, createdTime=Sat Nov 26 08:08:00 CST 2016, time=2016-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543477, encodeId=580c15434e7ba, content=<a href='/topic/show?id=274e340e5fd' target=_blank style='color:#2F92EE;'>#医学奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34075, encryptionId=274e340e5fd, topicName=医学奖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=250d13588803, createdName=斯嘉莉, createdTime=Sat Nov 26 08:08:00 CST 2016, time=2016-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1575397, encodeId=da1715e53974f, content=<a href='/topic/show?id=fab8393e4f9' target=_blank style='color:#2F92EE;'>#吴阶平医学奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39374, encryptionId=fab8393e4f9, topicName=吴阶平医学奖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd2816125954, createdName=s_pl2013, createdTime=Sat Nov 26 08:08:00 CST 2016, time=2016-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=157934, encodeId=8f5915e93408, content=牛人牛人!, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Thu Nov 24 20:21:03 CST 2016, time=2016-11-24, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=158309, encodeId=2e6815830948, content=支持支持, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1cdf1948157, createdName=Peter程, createdTime=Sat Nov 26 16:23:08 CST 2016, time=2016-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1394253, encodeId=8e431394253c5, content=<a href='/topic/show?id=796549911d9' target=_blank style='color:#2F92EE;'>#张伯礼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49911, encryptionId=796549911d9, topicName=张伯礼)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/E33DC517C2EC449E463E3D01D81745BA/100, createdBy=75e12500157, createdName=ms1756883563247400, createdTime=Sat Nov 26 08:08:00 CST 2016, time=2016-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457286, encodeId=fc9f145e2865c, content=<a href='/topic/show?id=089e393e1c4' target=_blank style='color:#2F92EE;'>#吴阶平#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39371, encryptionId=089e393e1c4, topicName=吴阶平)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64955868177, createdName=zhmscau, createdTime=Sat Nov 26 08:08:00 CST 2016, time=2016-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543477, encodeId=580c15434e7ba, content=<a href='/topic/show?id=274e340e5fd' target=_blank style='color:#2F92EE;'>#医学奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34075, encryptionId=274e340e5fd, topicName=医学奖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=250d13588803, createdName=斯嘉莉, createdTime=Sat Nov 26 08:08:00 CST 2016, time=2016-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1575397, encodeId=da1715e53974f, content=<a href='/topic/show?id=fab8393e4f9' target=_blank style='color:#2F92EE;'>#吴阶平医学奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39374, encryptionId=fab8393e4f9, topicName=吴阶平医学奖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd2816125954, createdName=s_pl2013, createdTime=Sat Nov 26 08:08:00 CST 2016, time=2016-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=157934, encodeId=8f5915e93408, content=牛人牛人!, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Thu Nov 24 20:21:03 CST 2016, time=2016-11-24, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=158309, encodeId=2e6815830948, content=支持支持, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1cdf1948157, createdName=Peter程, createdTime=Sat Nov 26 16:23:08 CST 2016, time=2016-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1394253, encodeId=8e431394253c5, content=<a href='/topic/show?id=796549911d9' target=_blank style='color:#2F92EE;'>#张伯礼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49911, encryptionId=796549911d9, topicName=张伯礼)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/E33DC517C2EC449E463E3D01D81745BA/100, createdBy=75e12500157, createdName=ms1756883563247400, createdTime=Sat Nov 26 08:08:00 CST 2016, time=2016-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457286, encodeId=fc9f145e2865c, content=<a href='/topic/show?id=089e393e1c4' target=_blank style='color:#2F92EE;'>#吴阶平#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39371, encryptionId=089e393e1c4, topicName=吴阶平)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64955868177, createdName=zhmscau, createdTime=Sat Nov 26 08:08:00 CST 2016, time=2016-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543477, encodeId=580c15434e7ba, content=<a href='/topic/show?id=274e340e5fd' target=_blank style='color:#2F92EE;'>#医学奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34075, encryptionId=274e340e5fd, topicName=医学奖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=250d13588803, createdName=斯嘉莉, createdTime=Sat Nov 26 08:08:00 CST 2016, time=2016-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1575397, encodeId=da1715e53974f, content=<a href='/topic/show?id=fab8393e4f9' target=_blank style='color:#2F92EE;'>#吴阶平医学奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39374, encryptionId=fab8393e4f9, topicName=吴阶平医学奖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd2816125954, createdName=s_pl2013, createdTime=Sat Nov 26 08:08:00 CST 2016, time=2016-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=157934, encodeId=8f5915e93408, content=牛人牛人!, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Thu Nov 24 20:21:03 CST 2016, time=2016-11-24, status=1, ipAttribution=)]
    2016-11-24 1dd8c52fm63(暂无匿称)

    牛人牛人!

    0

相关资讯

张伯礼院士:应加快制定《国民健康法》

“保障公民健康权益和国家战略利益,需要依靠法治这一国之重器。因此,需要加快制定《国民健康法》。”全国人大代表、中国工程院院士张伯礼日前表示,随着经济快速发展,我国的人口结构、生产生活方式、疾病谱及自然环境也发生巨大变化,居民的健康问题和疾病负担越发严峻。 “首先是老龄化问题突出。目前,我国60岁以上人口有2亿,而到2030年,老龄人口将超过3亿。届时,我国将成为全球人口老龄化程度最高的国家之

张伯礼院士:国人出国买药国内药企应反思

保障国民健康权益,需要依靠法治这一国之重器,应该加快制定国民健康法。”昨天,全国人大代表、中国工程院院士、中国中医科学院院长张伯礼接受记者采访时表示,应加快制定推动国民健康法,“有了上位法,才能依法协调做好健康管理各方面工作”。他还特意谈到今年春节大量国人去日本购药的现象,称国内药企应该反思,从全方位上改善服务,让老百姓用上更放心的药。 谈健康立法 青少年性早熟或与垃圾食品有关 每年两会

张伯礼院士:将中医药原创思维与现代科技结合

 张伯礼 中医药走向国际的前提是世界需要中医药,而科技是中医药走出去的翅膀,翅膀越硬飞得越高、飞得越远。 上个世纪末世界卫生组织做了一个调研,结论是现代的医学针对疾病的模式不可为继。提出维护健康是医学的主要目的,从疾病治疗转向预防为主,发现和发展人类自我健康能力是医学的任务,让人不得病,少得病,晚得病,不得大病,是医学研究的重点内容。中医药学养生保健、

张伯礼院士:二次开发赋予中成药新生命力

“临床需要‘好药’,产业需要‘大药’。”近日,中国工程院院士张伯礼在接受《中国科学报》记者采访时表示,中药有几千年的使用历史,但只有少部分品种具有较扎实的现代科研基础,中成药临床应用缺乏强有力的科技支撑。中医药是中华民族的瑰宝,千百年来积累了丰富的防病治病经验,至今仍发挥着重要作用。不过,相关数据显示,我国有近万个中成药品种,但2005年销售额过亿元的品种不足百个,过十亿元的大品种非常缺乏。为何中

中药重大新药创制显神威 张伯礼院士等分获多项国家科技进步奖

一、中成药二次开发核心技术体系创研及其产业化(国家科技进步奖,一等) 主要完成人:张伯礼、程翼宇、瞿海斌、刘洋、范骁辉、谢雁鸣、高秀梅、张平、刘雳、王毅、张俊华、康立源、胡利民、任明、张艳军。 中医药是我国独特的卫生资源,中药产业已成为我国独具特色和少数具有国际优势的产业之一。然而,中药科技基础相对薄弱,制约了中药品种做大做强。本项目从解决中成药品种个性化难题起步,聚焦于突破中

JACC:中药芪苈强心胶囊抗心衰疗效首获国际认可

据记者昨天从首届中西医血管病学大会获悉,我国抗心衰中成药芪苈强心胶囊的循证医学研究成果“登”上国际权威医学杂志《美国心脏病学会杂志》。该杂志编辑部表示:“中医药让衰竭的心脏更加强劲,该研究开启了心力衰竭治疗协同作用的希望之门。” 心力衰竭是各种心血管病的终末阶段。欧洲心脏病学会制定的心衰诊断首选指标为氨基末端B型利钠肽前体(NT-proBNP),它也是评价心衰药物疗效的主要指标。患者血清

Baidu
map
Baidu
map
Baidu
map